Internal Medicine, Pulmonary Disease · Baltimore, MD
NPI
1235242314
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4940 Eastern Ave
Baltimore, MD, 21224
Phone (410) 550-5864
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
591 services
Medicare patients, 2024
182
Average age 69
Drug cost, 2024
$2.7M
459 prescriptions
Company payments, 2025
$15K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen C Mathai was code 99232 (hospital e&m - subsequent), 172 times for 64 patients. In total Stephen C Mathai billed 591 services in 20 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 172 | 64 | $61.22 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 145 | 59 | $93.52 | $14K |
| 99215 Office E&M - Established | Facility | 118 | 65 | $114.55 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 69 | 48 | $13.22 | $912 |
| 99223 Hospital E&M - Initial | Facility | 38 | 38 | $132.87 | $5,049 |
| 99205 Office E&M - New | Facility | 16 | 16 | $148.31 | $2,373 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 15 | 11 | $25.40 | $381 |
By year: 2022 $43K for 405 services; 2023 $59K for 623 services; 2024 $47K for 591 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephen C Mathai prescribed most often to Medicare patients was Ambrisentan, with 98 prescriptions and refills. In total Stephen C Mathai wrote 459 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ambrisentan Generic | 98 | 124 | 12 | $701K |
| Adempas Riociguat | 60 | 62 | Under 11 | $847K |
| Sildenafil Citrate Generic | 40 | 90 | Under 11 | $24K |
| Furosemide Generic | 33 | 100 | 16 | $343 |
| Opsumit Macitentan | 29 | 37 | Under 11 | $455K |
| Tadalafil Generic | 26 | 64 | Under 11 | $120K |
| Spironolactone Generic | 23 | 63 | Under 11 | $333 |
| Xarelto Rivaroxaban | 22 | 22 | Under 11 | $6,416 |
| Orenitram Er Treprostinil Diolamine | 16 | 16 | Under 11 | $171K |
| Uptravi Selexipag | 14 | 14 | Under 11 | $209K |
| Bosentan Generic | 12 | 12 | Under 11 | $15K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 11 | 17 | Under 11 | $713 |
Brand drugs: 181 claims; generic drugs: 278 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen C Mathai $15K ($15K in general payments such as food, travel and fees) from 2 companies. The largest payer was Merck Sharp & Dohme LLC with $15K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.